skip to primary navigationskip to content

Owlstone Medical Opens New Breath Biopsy Lab

last modified Mar 23, 2017 08:59 AM
Tony Blair officially opened the new high volume lab in Cambridge last week

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the company’s new high volume clinical laboratory.

During the visit, Mr Blair learned more about the company’s Breath Biopsy® technology and its mission to save 100,000 lives and $1.5 billion in healthcare costs. He was also given a tour of Owlstone Medical headquarters including the new clinical lab and other research facilities.

The opening of a new clinical lab with increased capacity enables Owlstone Medical to offer high quality and high throughput Biomarker Services to academics, clinicians, pharmaceutical companies and CROs to identify novel breath biomarkers for disease diagnostics as well as precision medicine applications including therapeutic response, patient stratification and outcome prediction.

The clinical lab also provides VOC biomarker analysis of breath samples and other biospecimens from the on-going clinical trials in Owlstone Medical’s own clinical pipeline: early detection of lung cancer (LuCID), colorectal cancer (InTERCEPT) and treatment stratification in asthma (STRATA).

Billy Boyle, co-founder and CEO at Owlstone Medical commented: “Our new high volume clinical lab follows the successful commercial launch of our Biomarker Services earlier this year and the announcement of our first clinical and pharma customers. Having a state-of-the-art and globally unique capability allows us to increase capacity to handle large service projects as well as support our ongoing clinical trials.”

Tony Blair said: “I congratulate Owlstone Medical on the opening of its new clinical lab. It was a pleasure to meet the dedicated staff of this successful, dynamic company, united in their clear vision to save lives. The breath biopsy technology has huge potential to lead to great improvements in healthcare, and I wish the team every success in developing a company that will become a leader in next generation diagnostics.”

Mr Blair also visited ideaSpace West to meet some other Cambridge founders.

To find out more about Owlstone Medical visit: www.owlstonemedical.com

RSS Feed Latest news

Elpis Biomed, GeoSpock and Owlstone Win Cambridge Independent Science and Technology Awards

Nov 04, 2018

Elpis Biomed, based at IdeaSpace South, has scooped 'Start-Up of the Year' award at the Cambridge Independent Science and Technology Awards 2018. ideaSpace alumni Owlstone Medical also took home 'Medtech Company of the Year' and GeoSpock won the 'Technology Company of the Year' award. Congratulations to all!

LESSONS FROM A FOUNDER: Tips for Successful Product Design

Oct 26, 2018

Coming up with an idea for a product is the easy bit - it's the designing of it that can be a complicated and costly process. At a recent ideaSpace event we heard from four founders who offered their insights on how you can build a successful product that your customers are going to love. Read on for tips from our experts.

Camallergy Appoints Baxter Phillips III as CEO

Oct 25, 2018

Camallergy, based at ideaSpace South, a biopharmaceutical company dedicated to providing patient-centric treatments for life-threatening food allergies, has announced the appointment of Baxter Phillips III as Chief Executive Officer. Camallergy co-founder Sherden Timmins continues his executive appointment in the newly created role of Chief Operating Officer.

Mixcloud Strike a Multi-Year Agreement With Universal Music Group 

Oct 19, 2018

ideaSpace West member Mixcloud has signed a deal with the world's largest record label.

Riverlane and dividiti Ring the Bell to Celebrate Hackathon

Oct 18, 2018

ideaSpace West members Riverlane and dividiti celebrate after a successful quantum computing hackathon.

View all news